The Yatharth Hospital & Trauma Care Services IPO came to the Indian stock market in July 2023. The company operates a chain of multi-specialty hospitals, mainly in the Delhi-NCR region. Because the healthcare sector in India is expanding rapidly, the IPO attracted strong investor interest.
But the key question is: Was the Yatharth Hospital IPO good or bad for investors?
Let’s analyze it step by step.
About Yatharth Hospital
Yatharth Hospital & Trauma Care Services Limited is a healthcare provider that operates multi-specialty and super-specialty hospitals. The company mainly focuses on advanced medical treatments and trauma care services.
Key highlights:
- Founded in 2008
- Operates hospitals mainly in Noida, Greater Noida, and Delhi-NCR
- More than 2,300 hospital beds across its network
The company provides services in areas like:
- Cardiology
- Neurology
- Oncology
- Orthopedics
- Trauma care
Healthcare services are considered a defensive sector, meaning demand remains strong even during economic slowdowns.
Yatharth Hospital IPO Details
Here are the key details of the IPO:
- IPO opening date: 26 July 2023
- IPO closing date: 28 July 2023
- Listing date: 7 August 2023
- Price band: ₹285 – ₹300 per share
- Issue size: about ₹686.55 crore
- Lot size: 50 shares
- Listing exchange: NSE and BSE
The IPO consisted of:
- Fresh issue: around ₹490 crore
- Offer for sale: about ₹197 crore
The company planned to use the funds mainly for:
- Debt repayment
- Hospital expansion
- Capital expenditure
Subscription Demand
The IPO received very strong investor demand.
- Total subscription: about 36–37 times
Category-wise demand:
- QIB (institutional investors): about 85x
- NII (HNI investors): about 37x
- Retail investors: about 8x
Such strong subscription usually signals high investor confidence.
Listing Performance
The IPO delivered small but positive listing gains.
- Issue price: ₹300
- Listing price: around ₹306
- Listing gain: about 2%
This means investors who sold on listing day made only a small profit.
Current Stock Performance
The interesting part is the long-term performance.
- Current share price around ₹670–₹700
- Market cap about ₹6,700 crore
Compared to the IPO price of ₹300, the stock has delivered more than 120% return since listing.
In fact, some well-known investors have shown interest in the company. News reports mention that ace investor Vijay Kedia acquired about a 1% stake, reflecting confidence in its growth potential.
Financial Snapshot
Important financial indicators at the time of the IPO included:
- Revenue around ₹520 crore
- Net profit around ₹65 crore
- EBITDA margin about 25%
These numbers show a profitable hospital business with decent margins.
Strengths of Yatharth Hospital
1. Growing Healthcare Sector
India’s healthcare industry is expanding due to rising population, urbanization, and increasing medical demand.
2. Strong Hospital Network
The company has established hospitals in high-population regions like Delhi-NCR, which ensures steady patient demand.
3. Strong IPO Demand
The IPO’s 36x subscription reflected strong investor interest.
4. Good Post-Listing Returns
The stock has more than doubled since IPO, benefiting long-term investors.
Risks and Weaknesses
1. Regional Concentration
Most of the company’s hospitals are located in the Delhi-NCR region, which limits geographic diversification.
2. Capital-Intensive Business
Hospitals require large investments in infrastructure, equipment, and staff.
3. Competition
The hospital sector includes strong competitors such as:
- Apollo Hospitals
- Fortis Healthcare
- Max Healthcare
Competition can affect pricing and margins.
Final Verdict – Is Yatharth Hospital IPO Good or Bad?
Short answer: The Yatharth Hospital IPO turned out to be a good IPO for long-term investors.
Positive Points
- Strong subscription (36x)
- Profitable healthcare business
- Stock price more than doubled since IPO
Negative Points
- Only small listing gain
- Regional concentration of hospitals
Overall Rating
8/10 – A good IPO with strong long-term performance.
Short-term investors received small listing gains, but long-term investors have seen excellent returns due to strong growth in the hospital business.
